Clinical trials: Severe Skin Burns

Burns

Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns

• Active, not recruiting
• Age: 18 to 75 years
• Medical device
• Surgery or procedure

This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable Temporizing Matrix (BTM).

Trial name

NCT04090424

Testing

NovoSorb BTM, Standard of Care

Where

26 sites in United States, India

Volunteers

150 people

Sponsor

PolyNovo Biomaterials Pty Ltd.